Ica Group Wealth Management, LLC X4 Pharmaceuticals, Inc Transaction History
Ica Group Wealth Management, LLC
- $493 Million
- Q1 2024
A detailed history of Ica Group Wealth Management, LLC transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, Ica Group Wealth Management, LLC holds 2,750 shares of XFOR stock, worth $1,595. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,750
Previous 2,575
6.8%
Holding current value
$1,595
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding XFOR
# of Institutions
106Shares Held
103MCall Options Held
206KPut Options Held
291K-
Bain Capital Life Sciences Investors, LLC Boston, MA16.9MShares$9.81 Million3.55% of portfolio
-
Nea Management Company, LLC Timonium, MD15MShares$8.69 Million1.46% of portfolio
-
Black Rock Inc. New York, NY8.74MShares$5.07 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.83MShares$4.54 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.13MShares$4.14 Million0.22% of portfolio
About X4 Pharmaceuticals, Inc
- Ticker XFOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,646,096
- Market Cap $39.8M
- Description
- X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...